Table 2.
Phenotype | UK Biobank | Procardis | IMPROVE | SCARFSHEEP | Maximum N |
---|---|---|---|---|---|
BMI* | Y | Y | Y | Y | 416136 |
WHRadjBMI* | Y | Y | Y | Y | 416136 |
SBP* | Y | Y | Y | Y | 397163 |
DBP* | Y | Y | Y | Y | 397163 |
Diabetes* | Y | Y | Y | Y | 417615 |
Current smoking* | Y | Y | Y | Y | 416136 |
CVD | Y | Y | Y | 414116 | |
TGs* | Y | Y | Y | 14799 | |
CRP* | Y | Y | Y | 14799 | |
HDL* | Y | Y | Y | 14799 | |
LDL* | Y | Y | Y | 14799 | |
Glucose*^ | Y | Y | Y | 10128 | |
Insulin*^ | Y | Y | Y | 10128 | |
HOMA-IR*^ | Y | Y | Y | 10128 | |
HOMA-B*^ | Y | Y | Y | 10128 | |
BD | Y | 129366 | |||
GAD | Y | 90536 | |||
MDD | Y | 109436 | |||
Addiction | Y | 129858 | |||
Mood instability | Y | 393367 | |||
Risk taking | Y | 328339 | |||
Neuroticism | Y | 328087 |
Where: WHRadjBMI, waist:hip ratio adjusted for BMI; ISH, ischemic heat disease, including myocardial infarction and coronary artery disease; BD, bipolar disorder; GAD, general anxiety disorder; MDD, major depressive disorder; addiction, any addiction. All models adjusted for age, sex and population structure. *Additional adjustment for CVD status. ^Participants with T2D excluded from these analyses.